Get the tools used by (smart)2 investors.

Cash And Short Term Investments for Cytosorbents Crp

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

CTSO: Cytosorbents Crp

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous...

1.00 USD
Price
USD
Fair Value
Upside
0.70 - 1.61
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Cytosorbents Crp's Cash And Short Term Investments:

Dec 2015Dec 2017Dec 2019Dec 2021Dec 20230 K20 M40 M60 M80 M

Performance Summary
  • Cytosorbents Crp's cash and short term investments last quarter was 5.685 million
  • Cytosorbents Crp's cash and short term investments for fiscal years ending December 2019 to 2023 averaged 34.413 million.
  • Cytosorbents Crp's operated at median cash and short term investments of 22.145 million from fiscal years ending December 2019 to 2023.
  • Looking back at the last 5 years, Cytosorbents Crp's cash and short term investments peaked in December 2020 at 71.422 million.
  • Cytosorbents Crp's cash and short term investments hit its 5-year low in December 2019 of 12.232 million.
  • Cytosorbents Crp's cash and short term investments decreased in 2019 (12.232 million, -45.3%), 2021 (52.138 million, -27.0%), 2022 (22.145 million, -57.5%), and 2023 (14.131 million, -36.2%) and increased in 2020 (71.422 million, +483.9%).

How does Cytosorbents Crp's Cash And Short Term Investments benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Cytosorbents Crp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Cash And Short Term Investments

Hide this widget
cash_st
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Cash And Short Term Investments in the financials category include:

  • Stock-Based Comp, Unallocated - Stock-Based Comp., Other (Total) is a supplemental line item that represents stock based compensation disclosed by the company but not associated with a particular operating expense - values can be either main table line items or standalone values This item includes: Stock purchase discount Incentive stock and other compensation. ESOP expense Stock price related incentive program Stock appreciation right expense or stock discount Non-cash stock compensation Discretionary ESOP contribution Non-cash imputed (ESOP) compensation expense Contributions to employee profit sharing and employee stock option plan. Compensatory element of stock issuance Transaction related compensation charge. Non-recurring compensation expense on option grants. Share based plans.
  • Merger & Restructuring Charges - This item represents the sum of one-time Merger and Restructuring charges incurred by the company.
  • Accounts Receivable, Net - The total amount of collectibles for a company net of receivables that are deemed to be uncollectible.
  • Real Estate Owned - Real estate and other properties reported separately from other plant, property and equipment fields.
View Full List

Search for metric or datapoint

Cash And Short Term Investments

Cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly li...

Definition of Cash And Short Term Investments

Hide this widget

Cytosorbents reported cash and short term investments of 5.685 M for the latest quarter ending September 30, 2024 on its balance sheet.

The tables below summarizes Cytosorbents’s Cash And Short Term Investments and common size over the last five years:

Fiscal YearCash And Short Term InvestmentsAssets% Assets
2019-12-3112.232 M27.383 M44.7%
2020-12-3171.422 M89.95 M79.4%
2021-12-3152.138 M89.519 M58.2%
2022-12-3122.145 M63.232 M35.0%
2023-12-3114.131 M53.261 M26.5%

The tables below summarizes Cytosorbents’s Cash And Short Term Investments and common size over the last four quarters:

Quarter EndingCash And Short Term InvestmentsAssets% Assets
2023-12-3114.131 M53.261 M26.5%
2024-03-318.608 M47.071 M18.3%
2024-06-308.459 M53.427 M15.8%
2024-09-305.685 M47.804 M11.9%

Click the link below to download a spreadsheet with an example Cash And Short Term Investments calculation for Cytosorbents Crp below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
59.559 M809.6 M1.56 B2.918 B0100200

The chart above depicts the distribution of cash and short term investments for companies operating in the Healthcare sector in the Developed economic region. Over 2,480 companies were considered in this analysis, and 2,385 had meaningful values. The average cash and short term investments of companies in the sector is 139.6 M with a standard deviation of 328.1 M.

Cytosorbents Crp's Cash And Short Term Investments of 5.685 M ranks in the 35.4% percentile for the sector. The following table provides additional summary stats:

Cash And Short Term Investments In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,485
Included Constituents2,385
Min3.409 K
Max2.915 B
Median16.591 M
Mean139.6 M
Standard Deviation328.1 M

You can find companies with similar cash and short term investments using this stock screener.

All rights reserved. Terms Of Use